# Phase 2 Chronic Pain trials recruiting: 24 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials in phase 2 for Chronic Pain that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Chronic Pain trials: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/chronic-pain

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07937332 | OXytocin For Opioid Respiratory Depression | George Washington University | Phase 2 | Not yet recruiting | Chronic Pain, Intranasal Drug Administration, Oxytocin, Chronic Pain (Back / Neck) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937332) |
| October 15, 2026 | NCT07874620 | A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain | Adneuris Therapeutics, Inc. | Phase 2 | Recruiting | Chronic Pain, Pain, Opioid Withdrawal (Disorder), Opioid Use Disorder | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874620) |
| October 9, 2026 | NCT07868536 | Post-traumatic Estradiol Administration and Care Evaluation (PEACE) | University of North Carolina, Chapel Hill | Phase 2 | Not yet recruiting | Chronic Musculoskeletal Pain, Sexual Assault, Posttraumatic Stress Disorder (PTSD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868536) |
| August 24, 2026 | NCT07783295 | Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Chronic Pain, Fibromyalgia, Osteoporosis, Orofacial Pain | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783295) |
| August 10, 2026 | NCT07755540 | Group Music Therapy for Chronic Pain Management in Active Duty Service Members | Henry M. Jackson Foundation for the Advancement of Military Medicine | Phase 2 | Recruiting | Chronic Pain | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755540) |
| June 11, 2026 | NCT07641517 | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain | Eli Lilly and Company | Phase 2 | Recruiting | Osteoarthritis, Knee, Chronic Pain | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641517) |
| June 11, 2026 | NCT07641504 | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain | Eli Lilly and Company | Phase 2 | Recruiting | Chronic Pain, Low Back Pain | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641504) |
| November 25, 2025 | NCT07247006 | Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression | University of Rochester | Phase 2 | Not yet recruiting | Treatment Resistant Depression (TRD), Chronic Pain | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247006) |
| July 18, 2025 | NCT07072468 | Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) | VM Therapeutics LLC | Phase 2 | Recruiting | Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain, CIPN - Chemotherapy-Induced... | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07072468) |
| April 27, 2025 | NCT06946940 | Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia | Rambam Health Care Campus | Phase 2 | Recruiting | Fibromyalgia | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06946940) |
| February 20, 2025 | NCT06837857 | Prescription Opioids, Brain Structure, and Cognition in Older Adults With Chronic Pain | Mayo Clinic | Phase 2 | Recruiting | Pain, Chronic | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06837857) |
| January 29, 2025 | NCT06800209 | Pain Reprocessing Therapy in Post-Operative Knee Pain | Weill Medical College of Cornell University | Phase 2 | Recruiting | Pain, Chronic, Knee Pain Chronic | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06800209) |
| December 12, 2024 | NCT06731335 | Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN | Unity Health Toronto | Phase 2 | Recruiting | Chronic Neuropathic Pain, Pain Management | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06731335) |
| October 2, 2024 | NCT06623669 | A Mobile Intervention to Reduce Pain and Improve Health-III | Wake Forest University | Phase 2 | Recruiting | Chronic Pain, Osteoarthritis, Obesity and Overweight, Inactivity | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06623669) |
| August 9, 2024 | NCT06544291 | Combined THC and CBD for OUD and Chronic Pain | Yale University | Phase 2 | Recruiting | Chronic Pain, Opioid Use Disorder | 147 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06544291) |
| July 24, 2024 | NCT06518720 | Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND) | Centre for Addiction and Mental Health | Phase 2 | Recruiting | Treatment Resistant Depression, Chronic Pain | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06518720) |
| June 12, 2024 | NCT06454669 | Dronabinol as an Adjunct for Reducing Pain | Sponsor not shown (see the record) | Phase 2 | Recruiting | Low Back Pain, Chronic Pain, Back Injuries | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06454669) |
| January 19, 2024 | NCT06213233 | MIVetsCan: Cannabidiol (CBD)-Care Trial | Sponsor not shown (see the record) | Phase 2 | Recruiting | Pain, Chronic | 468 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06213233) |
| March 30, 2023 | NCT05790239 | MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder | Sponsor not shown (see the record) | Phase 2 | Recruiting | Post Traumatic Stress Disorder | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05790239) |
| January 13, 2023 | NCT05684692 | Screening Trial for Pain Relief in Schwannomatosis (STARFISH) | Massachusetts General Hospital | Phase 2 | Recruiting | Schwannomatosis, Schwannomas, Pain, Chronic | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05684692) |
| December 22, 2022 | NCT05661903 | From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects | Massachusetts General Hospital | Phase 2 | Recruiting | Chronic Pain | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05661903) |
| October 18, 2022 | NCT05585229 | Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication | University of British Columbia | Phase 2 | Recruiting | Opioid Dependence, Chronic Pain | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05585229) |
| March 17, 2022 | NCT05285683 | The Role of Brain Dopamine in Chronic Pain | University of Rochester | Phase 2 | Recruiting | Chronic Pain | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05285683) |
| June 25, 2021 | NCT04939623 | Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal | University of Calgary | Phase 2 | Recruiting | Chronic Pain, Drug Dependence of Morphine Type, Symptom, Withdrawal | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04939623) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Massachusetts General Hospital | 2 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 2 |
| University of Rochester | 2 |
| Centre for Addiction and Mental Health | 1 |
| George Washington University | 1 |
| Rambam Health Care Campus | 1 |
| University of North Carolina, Chapel Hill | 1 |
| Wake Forest University | 1 |
| University of Calgary | 1 |
| Mayo Clinic | 1 |
| Weill Medical College of Cornell University | 1 |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | 1 |
| Unity Health Toronto | 1 |
| Adneuris Therapeutics, Inc. | 1 |
| University of British Columbia | 1 |
| Yale University | 1 |
| VM Therapeutics LLC | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 15 |
| Canada | 4 |
| Puerto Rico | 2 |
| Israel | 1 |
| Brazil | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Cocktail bars in the United States](https://specstream.ai/data/businesses/cocktail-bars/united-states)
- [Real estate firms in the United States](https://specstream.ai/data/businesses/real-estate-firms/united-states)
- [Energy companies in the United States](https://specstream.ai/data/businesses/energy-companies/united-states)
- [Temp agencies in the United States](https://specstream.ai/data/businesses/temp-agencies/united-states)
- [High schools in the United States](https://specstream.ai/data/businesses/high-schools/united-states)
- [African restaurants in the United States](https://specstream.ai/data/businesses/african-restaurants/united-states)
